Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

UFS closes pedestrian entrances to improve safety on campus
2010-08-05

The University of the Free State (UFS) will remove pedestrian gates on its Main Campus in an extra effort to improve safety on this campus.

It was decided to implement this plan because the campus covers a huge area and people who are not part of the campus community hang around on the campus, sometimes causing damages. This idea is also strongly supported by students, in particular with regard to the removal of the pedestrian thoroughfares close to the hostels.

The following pedestrian gates will not be removed:

- The pedestrian thoroughfares on both sides of the DF Malherbe Gate (next to the Faculty of Health Sciences). Both the main gate and the pedestrian thoroughfares at the DF Malherbe Gate remain open 24 hours a day.
- The pedestrian thoroughfares at the Badenhorst Street Gate (close to Roosmaryn Residence). The Badenhorst Gate is not open 24 hours a day, but the pedestrian thoroughfare will remain open 24 hours a day.

The following pedestrian thoroughfares will be removed with effect from 1 September 2010:

- The pedestrian thoroughfare to the east of Pellies Park
- The pedestrian thoroughfare to the west of Pellies Park (directly behind JMB Hertzog Residence)
- The turnstile between the Kovsie Church and the Wynand Mouton Gate
- The pedestrian thoroughfare behind the tennis courts
- The pedestrian thoroughfares behind the rugby fields

A request was also directed at the Kovsie Church to close down the pedestrian thoroughfare between the Kovsie Church and the UFS. This gate will then be opened during church activities.

From 1 September 2010, the personnel of Security Services will regularly patrol the fences. Trespassers that flatten the fencing to enter the campus will be prosecuted.

Students, personnel and visitors are encouraged to make use of the main entrance gates of the UFS. These include the Main Gate (in Nelson Mandela Drive), the Wynand Mouton Gate (in DF Malherbe Drive), the DF Malherbe Gate (in Wynand Mouton Drive), the Badenhorst Street Gate (close to Roosmaryn Residence) and the Furstenburg Gate (in Furstenburg Road).

Media Release:
Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
5 August 2010

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept